DiaMedica Therapeutics Inc.DMACNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-22.10M
↓ 128% below average
Average (9y)
$-9.71M
Historical baseline
Range
High:$-1.37M
Low:$-22.10M
CAGR
+36.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-22.10M | -17.9% |
| 2023 | $-18.75M | -61.8% |
| 2022 | $-11.59M | +5.6% |
| 2021 | $-12.27M | -33.0% |
| 2020 | $-9.23M | -1.4% |
| 2019 | $-9.10M | -58.4% |
| 2018 | $-5.75M | -46.5% |
| 2017 | $-3.92M | -29.4% |
| 2016 | $-3.03M | -121.0% |
| 2015 | $-1.37M | - |